Application | Comment | Organism |
---|---|---|
medicine | vildagliptin is a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. No adjustment in dosage based on pharmacokinetic considerations is required should vildagliptin be coadministered with amlodipine, valsartan, or ramipril in patients with type 2 diabetes and hypertension | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
vildagliptin | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |